Products Overview News Today

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED...

INNSBRUCK, Austria, April 2, 2024 /PRNewswire/ -- In an era when digital threats are constantly multiplying and evolving, it's more important than ever to

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating)’s stock price hit a new 52-week high on Thursday . The stock traded as high as $84.61 and last traded at $84.13, with a volume of 396981 shares trading hands. The stock had previously closed at $80.91. Wall Street Analyst Weigh In AXSM has been the topic of […]

Endurant Capital Management LP bought a new stake in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) in the fourth quarter, Holdings Channel.com reports. The firm bought 11,264 shares of the company’s stock, valued at approximately $869,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […]

Driehaus Capital Management LLC bought a new position in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 233,095 shares of the company’s stock, valued at approximately $17,979,000. A number of other institutional investors and hedge funds also recently made changes to their positions in the […]

Shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. […]

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating)’s share price was up 4% during mid-day trading on Wednesday . The stock traded as high as $72.47 and last traded at $72.24. Approximately 294,226 shares changed hands during trading, a decline of 67% from the average daily volume of 884,269 shares. The stock had previously closed at […]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD SPECIALIZED... | May 30, 2023

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Rating) – Analysts at Zacks Research cut their Q2 2023 earnings per share (EPS) estimates for shares of Axsome Therapeutics in a research note issued on Monday, May 22nd. Zacks Research analyst K. Shah now expects that the company will post earnings of ($1.32) per share for the quarter, […]

Axsome Therapeutics (NASDAQ:AXSM – Get Rating) had its price objective upped by Guggenheim from $90.00 to $100.00 in a research report sent to investors on Tuesday morning, The Fly reports. AXSM has been the topic of a number of other research reports. StockNews.com began coverage on Axsome Therapeutics in a research report on Thursday, March […]